Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue 2, 1996, Pages 215-226

  Ross, Danna L ^a   Schultz, Robert K ^a,b  

^a 3M COMPANY   (United States)

^b Dura Pharmaceuticals   (United States)

Author keywords

dosing characteristics; DPI; dry powder inhaler; inhalation flow rate; MDI; medication delivery; metered dose inhaler; particle size; respirable dose

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; SALBUTAMOL; TERBUTALINE; TERBUTALINE SULFATE;

AEROSOL; ARTICLE; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UPTAKE; INSPIRATORY CAPACITY; PHARMACEUTICS;

EID: 0029973878     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.215     Document Type: Article

References (20)

1. Schultz, R.K., N.C. Miller, D.K. Smith, and D.L. Ross. 1992. Powder aerosols with auxiliary means or dispersion. J. Biopharm. Sci. 3:115-121.
2. Hindle, H., R.N. Jashnani, and P.R. Byron. 1994. Dose emissions from marketed inhalers: Influence of flow, volume and environment. Proc. Respir. Drug Delivery IV, Richmond, VA, May 1-6.
3. Hindle, H., and R. Byron. 1995. Dose emissions from marketed dry powder inhalers. Int. J. Pharm. 116:169-177.
4. Borgstrom, L., and S. Newman. 1993. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler. Int. J. Pharm. 97:47-53.
5. Engel, T., J.H. Heinig, H.J. Malling, B. Scharling, K. Nikander, and F. Madsen. 1989. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbohaler. Allergy 44:220-225.
6. Engel, T., J.H. Heinig, F. Madsen, and K. Nikander. 1990. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur. Respir. J. 3:1037-1041.
7. Engel, T., B. Scharling, B. Skovsted, and J.H. Heinig. 1992. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes. Br. J. Clin. Pharmacol. 33:439-444.
8. Pedersen, S., and G. Steffensen. 1986. Fenoterol powder inhaler technique in children: Influence of inspiratory flow rate and breath-holding. Eur. J. Respir. Dis. 68:207-214.
9. Pedersen, S., O.R. Hansen, and G. Fuglsang. 1990. Influence of inspiratory flow rate upon the effect of Turbohaler. Arch. Dis. Child. 65:308-319.
10. Johnsen, C.R., and E.R. Weeke. 1987. Turbohaler - a new device for dry powder terbutaline sulphate inhalation: Therapeutic effect in comparison with metered dose inhaler in adults. In S.P. Newman, F. Moren, and G.K. Crompton, eds. A New Concept in Inhalation Therapy. Proceedings of an International Workshop on a New Inhaler. Medicom, London, U.K., 131-135.
11. Bronsky, E., G.A. Bucholtz, W.W. Busse, P. Chervinsky, J. Condemi, M.A. Ghafouri, L. Hudson, S. Lakshminarayan, R. Lockey, M.E. Reese, S.I. Rennard, A. Segal, L. Smolley, S. Spector, J.J. Stablein, A.V. As, and A. Wilson. 1987. Comparison of inhaled albuterol powder and aerosol in asthma. J. Allergy Clin. Immunol. 79(5):741-747.
12. Zainudin, B.Z., M. Biddiscombe, S.E. Tolfree, M. Short, and S.G. Spiro. 1990. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 45:469-473.
13. Hetzel, M.R., and T.J. Clark. 1977. Comparison of salbutamol Rotahaler with conventional pressurized aerosol. Clin. Aller. 7:563-568.
14. Dolovich, M.B., M.L. Vanzielegham, K.G. Hidinger, and M.T. Newhouse. 1988. Influence of inspiratory flow rate on the response to terbutaline sulphate inhaled via the Turbuhaler. Am. Rev. Respir. Dis. 137:A433.
15. Newman, S.P., F. Moren, E. Trofast, N. Talaee, and S.W. Clarke. 1991. Terbutaline sulphate Turbuhaler: Effect of inhaled flow rate on drug deposition and efficacy. Int. J. Pharm. 74:209-213.
16. Borgstrom, L., S. Newman, A. Weisz, and F. Moren. 1992. Pulmonary deposition of inhaled terbutaline: Comparison of scanning gamma camera and urinary excretion methods. J. Pharm. Sci. 81(8):753-755.
17. Clark, A.R., and M. Egan. 1994. Modelling the deposition of inhaled powdered drug aerosols. J. Aerosol Sci. 25:175-186.
18. Borgstrom, L., E. Bondesson, F. Moren, E. Trofast, and S. Newman. 1994. Lung deposition of budesonide inhaled via Turbuhaler®: A comparison with terbutaline sulphate in normal subjects. Eur. Respir. J. 7:69-73.
19. Trofast, E., and J. Andersson. 1988. Turbuhaler: Factors affecting the particle size distribution (Abstract). Seventh Int. Congr. Aerosols Med. Sept. 25-29. Rochester, N.Y.
20. Richards, R., and M. Saunders. 1993. Need for a comparative performance standard for dry powder inhalers. Thorax 48:1186-1187.